I don't know how to treat amyloidosis

Research output: Contribution to journalComment/debatepeer-review

23 Scopus citations


In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.

Original languageEnglish (US)
Pages (from-to)507-508
Number of pages2
Issue number4
StatePublished - Jul 29 2010

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'I don't know how to treat amyloidosis'. Together they form a unique fingerprint.

Cite this